Vittoria Biotherapeutics is a clinical-stage company with a novel platform technology, Senza5, that powers a pipeline of highly differentiated immunotherapies designed to address unmet clinical needs in oncology and immunology
Vittoria Biotherapeutics is a clinical-stage company with a novel platform technology, Senza5, that powers a pipeline of highly differentiated immunotherapies designed to address unmet clinical needs in oncology and immunology.